News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,707 Results
Type
Article (86446)
Company Profile (702)
Press Release (758559)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232656)
Career Advice (4126)
Deals (39715)
Drug Delivery (129)
Drug Development (90978)
Employer Resources (198)
FDA (18099)
Job Trends (17330)
News (396416)
Policy (39740)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (56818)
ALS (99)
Alzheimer's disease (1499)
Antibody-drug conjugate (ADC) (156)
Approvals (18066)
Artificial intelligence (319)
Autoimmune disease (29)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (84)
Brain cancer (31)
Breast cancer (299)
Cancer (2402)
Cardiovascular disease (202)
Career advice (3532)
Career pathing (34)
CAR-T (167)
Cell therapy (478)
Cervical cancer (21)
Clinical research (73353)
Collaboration (900)
Compensation (541)
Complete response letters (30)
COVID-19 (2864)
CRISPR (46)
C-suite (257)
Cystic fibrosis (107)
Data (2224)
Decentralized trials (2)
Denatured (45)
Depression (54)
Diabetes (294)
Diagnostics (6917)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (127)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96507)
Editorial (43)
Employer branding (25)
Employer resources (167)
Events (129820)
Executive appointments (764)
FDA (19402)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (813)
Gene editing (116)
Generative AI (35)
Gene therapy (351)
GLP-1 (848)
Government (5154)
Grass and pollen (6)
Guidances (53)
Healthcare (20885)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (143)
Indications (30)
Infectious disease (3025)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (100)
Interviews (812)
IPO (17808)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (552)
Leadership (22)
Legal (10113)
Liver cancer (80)
Lung cancer (342)
Lymphoma (156)
Machine learning (6)
Management (65)
Manufacturing (345)
MASH (73)
Medical device (14627)
Medtech (14632)
Mergers & acquisitions (22435)
Metabolic disorders (779)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (111)
Neuropsychiatric disorders (34)
Neuroscience (2091)
NextGen: Class of 2025 (7682)
Non-profit (5079)
Northern California (2698)
Now hiring (40)
Obesity (420)
Opinion (274)
Ovarian cancer (77)
Pain (95)
Pancreatic cancer (84)
Parkinson's disease (159)
Partnered (24)
Patents (248)
Patient recruitment (110)
Peanut (51)
People (65262)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22629)
Phase II (31844)
Phase III (24000)
Pipeline (1209)
Policy (168)
Postmarket research (3552)
Preclinical (10199)
Press Release (72)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (426)
Real estate (7392)
Recruiting (75)
Regulatory (26769)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (5)
RSV (50)
Schizophrenia (78)
Series A (142)
Series B (90)
Service/supplier (30)
Sickle cell disease (58)
Southern California (2342)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4290)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (41)
The Weekly (82)
United States (24340)
Vaccines (806)
Venture capitalists (44)
Weight loss (301)
Women's health (40)
Worklife (19)
Date
Today (250)
Last 7 days (835)
Last 30 days (2765)
Last 365 days (35940)
2025 (11246)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (268)
Arkansas (14)
Asia (50105)
Australia (8826)
California (6304)
Canada (2032)
China (552)
Colorado (282)
Connecticut (298)
Delaware (157)
Europe (114897)
Florida (918)
Georgia (217)
Hawaii (1)
Idaho (64)
Illinois (619)
India (31)
Indiana (331)
Iowa (12)
Japan (164)
Kansas (109)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (951)
Massachusetts (4865)
Michigan (243)
Minnesota (416)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1786)
New Mexico (31)
New York (1790)
North Carolina (1118)
North Dakota (8)
Northern California (2698)
Ohio (215)
Oklahoma (15)
Oregon (48)
Pennsylvania (1393)
Puerto Rico (12)
Rhode Island (36)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2342)
Tennessee (104)
Texas (946)
Utah (189)
Virginia (168)
Washington D.C. (69)
Washington State (598)
West Virginia (3)
Wisconsin (67)
There are 845,707 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Spruce Slashes 55% of Workforce
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
April 29, 2025
·
183 min read
·
BioSpace Editorial Staff
Layoffs
Octagon Winds Down After Deprioritizing Lead Program
Despite executing perfectly, Octagon confronted a “scientific no-go,” CEO Isaac Stoner said in his LinkedIn post announcing the company’s impending closure.
April 29, 2025
·
1 min read
·
Angela Gabriel
Rare diseases
Abeona Gets FDA Nod for Rare Skin Disease Gene Therapy
The condition, recessive dystrophic epidermolysis bullosa, causes chronic wounds and has an 84% mortality rate by age 40.
April 29, 2025
·
1 min read
·
Dan Samorodnitsky
Cancer
AACR 2025 Tracker: Roche Offers TIGIT Post-Mortem, Agenus Unveils ‘Promising’ Mid-Stage Data
The American Association for Cancer Research’s annual conference continued Monday with Roche providing details from its failed Phase III NSCLC study of anti-TIGIT therapy tiragolumab and Agenus claiming a Phase II win for its PD-1/CTLA-4 combo.
April 29, 2025
·
5 min read
·
BioSpace Editorial Staff
Earnings
Novartis CEO Brushes Off Tariffs but Says Trump Pricing Controls Would Be ‘Devastating’
Vas Narasimhan said on Tuesday that if the U.S. adopts international drug pricing, all companies would have to “relook at their medium- to long-term outlook.”
April 29, 2025
·
3 min read
·
Annalee Armstrong
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
April 29, 2025
·
3 min read
·
Tristan Manalac
Press Releases
PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement
April 29, 2025
·
5 min read
Press Releases
PlasCred Circular Innovations Inc. Announces First Closing of Private Placement and Amendment to Previously Announced Offering
April 29, 2025
·
3 min read
Press Releases
Tevard to Present Data Demonstrating tRNA-based Therapy Rescued Full-Length Dystrophin and Motor Function in Duchenne Muscular Dystrophy Model
April 29, 2025
·
2 min read
Press Releases
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors
April 29, 2025
·
6 min read
1 of 84,571
Next
